Drug Profile
Research programme: oxycodone immediate release - Ensysce Biosciences
Alternative Names: IR Oxycodone - Ensysce Biosciences; IR Oxycodone - PharmacoFore; IR Oxycodone Bio-MD™ System; PFR 06158Latest Information Update: 30 Dec 2022
Price :
$50
*
At a glance
- Originator Signature Therapeutics
- Developer Ensysce Biosciences
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for preclinical development in Pain in USA (PO, Immediate release)
- 24 Feb 2016 Research programme: oxycodone immediate release - Ensysce Biosciences is available for licensing as of 24 Feb 2016. www.ensysce.com
- 24 Feb 2016 Preclinical trials in Pain in USA (PO) before February 2016